Inovalon to Support National Vaccine Adherence Programs
Nation’s Largest Vaccine Manufacturer Spearheading Initiative BOWIE, Md., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading provider...
Day: November 9, 2020
Nextleaf Solutions Signs Cannabis Extraction Agreement with Eve & Co
VANCOUVER, British Columbia, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Nextleaf Solutions Ltd. ("Nextleaf Solutions", "OILS", or the "Company") (CSE: OILS)...
Forbes Recognizes Cerner Among World’s Best Employers
KANSAS CITY, Mo., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Today, Cerner Corporation (NASDAQ: CERN), a global health care technology company,...
Medexus Pharmaceuticals Schedules Second Quarter Fiscal 2021 Conference Call
Conference call to be held at 8:00 AM Eastern Time on Tuesday, November 17th, 2020 MONTREAL, Nov. 09, 2020 (GLOBE...
Resonant Releases New PMTx Extension For TC-SAW Filter Technologies
GOLETA, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency,...
Minerva Neurosciences to Present at Jefferies Virtual London Healthcare Conference
WALTHAM, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the...
IntelGenx Announces Publication of a Study Evaluating Montelukast’s Effect on Neurological Aging
- Data Suggest Montelukast May Inhibit Mental Decline, Higher Doses Optimal for Clinical Trials Assessing Impact on Neurological Disease -...
Entera Bio Ltd Announces Completion of Enrollment In Phase 2 Clinical Trial of Eb613 In Osteoporosis
‒ Company Expects to Report Interim 3 Month Biomarker Data for All Enrolled Patients in Q1:21 with Final Bone Mineral Density,...
Tonix Pharmaceuticals Reports Third Quarter 2020 Financial Results and Operational Highlights
Data from Animal Studies of COVID-19 Vaccine Candidate, TNX-1800, Expected in Fourth Quarter 2020 Phase 1 Safety Study in Humans...
Assure Reports a Record Number of Monthly Procedures in October 2020
Company Launches Two IONM-Related Clinical Research Projects DENVER, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or...
Beroni Group Named as a Top Infection Control Solutions Company in APAC for 2020
NEW YORK and SYDNEY, Australia, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the...
BioLife Sciences (OTCPK:BLFE) Initiates Process for Up-Listing to OTCQB
TORONTO, ONTARIO, Nov. 09, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – BioLife Sciences Inc. (OTCPK:BLFE) announces it has initiated the...
Exagen Inc. To Participate in November Investor Conferences
SAN DIEGO, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients...
Monopar Announces Issuance of New Patents Broadening Protections For Phase 2b/3 Clinical-Stage Lead Product Candidate Validive®
Strengthens Monopar’s Validive IP Portfolio To 2035 WILMETTE, Ill., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR),...
Novavax COVID-19 Vaccine Granted Fast Track Designation by U.S. FDA
GAITHERSBURG, Md., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious...
New Preclinical Data being Presented at SITC Underscore Promising Combinations of Affimed’s AFM13 and Cytokine-Activated Natural Killer Cells
Virtual data presentation at The Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting on Wednesday, November 11,...
Cassava Sciences Reports Third Quarter 2020 Financial Results
AUSTIN, Texas, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s...
Agenus Presents Additional Clinical Responses and Novel Biomarker Data at SITC2020
AGEN1181: New clinical responses and intratumoral Treg depletion AGEN1777 (TIGIT) is Fc enhanced for optimized immune performance & broader benefit...
ALX Oncology Announces New Data from ASPEN-01, the Phase 1b Study of ALX148, Showing Promising Initial Clinical Responses in Patients with Advanced Solid Tumors
-- ORR of 64% Observed in Patients with >2L HER2 Positive Gastric/Gastroesophageal Junction Cancer -- ORR of 75% and One...
BioXcel Therapeutics to Present BXCL701 Clinical Data at the Society for Immunotherapy of Cancer’s 35th Anniversary Annual Meeting
Encouraging signals of activity in difficult-to-treat tumors observed in both ongoing trials with BXCL701 and pembrolizumab (KEYTRUDA®) NEW HAVEN, Conn.,...